(844) 274-8497



Clinical Trials


The University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center leads several clinic trials within our Phoenix cancer center.

Below is a list of our active trials. Select the study name for specific information about that trial. For more information about how to participate in any of the clinical trials listed below, contact the Clinical Trials Office at 855.622.6845.

 

ABDOMINAL CANCER

David Row, MD, FACS, FASCRS

PHXE-17-0120-80-15

S1316, Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction

 

CUTANEOUS CANCER

Wong, Debra, MD

PHXE-16-0205-80-15

A Phase 2 Study of REGN2810, A fully Human Monoclonal Antibody to Programmed Death - 1 (PD-1), in Patients with Advanced Cutaneous Squamous Cell Carcinoma

Wong, Debra, MD

PHXE-17-0101-80-15

A Phase 2 Study of REGN2810, A Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

 

BREAST CANCER                                                                                                                           

Albert Wendt, MD

PHXA-17-0242-71-15

Aerobic Interval Exercise Preconditioning to Prevent Cardiometabolic and Neuropsychological Complications of Anthracycline Based Breast Cancer Chemotherapy

Albert Wendt, MD

PHXE-17-0374-10-15

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer

 

KIDNEY CANCER

Jue Wang, MD

PHXE-17-0114-10-15

A Phase 3 RandOmized Study Comparing PERioperative Nivolumab Vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

 

PRECISION MEDICINE

Jue Wang, MD

PHXE-17-0216-10-15

EAY131: Molecular Analysis for Therapy Choice (MATCH)

 

PROSTATE CANCER

Jue Wang, MD

PHXE-17-0128-80-15

An Open-Label Phase 1/2A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRC253, and Androgen Receptor Antagonist, in Patients with Metastatic Castration-Resistant Prostate Cancer

 

RARE TUMORS

Jue Wang, MD

PHXE-17-0349-10-15

 

SHERLOC: A Phase 2 Study of MM-121 in Combination with Docetaxel versus Docetaxel Alone in Patients with Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer

 

SUPPORTIVE

Wong, Debra, MD

PHXB-18-500-288-11-15

POST-CHEMO: Post-Chemo Symptom Management: Testing Intervention Sequences in a SMART Design